Evidence-gap map · non-drug interventions

Alopecia Areata evidence gaps

32 registered non-drug trials, mapped by approach and outcome.

Which non-drug approaches have been tested for Alopecia Areata, and which outcomes they were tested on. An empty cell means no matching trial was found among those searched: a possible gap, not proof that nobody has asked the question.

32registered non-drug trials
0with results posted
5recruiting as of 2026-11-16
18group × outcome cells with at least one trial
⚠️
Research information, not medical advice. These pages index what has been studied in registered trials. A trial existing, completing or posting results says nothing on its own about whether an approach works or is safe for you. Supplements and devices can interact with medicines. Discuss any change with your own clinician.

Evidence-gap matrix

Each number is the count of trials; "with results" is how many of them have posted results on ClinicalTrials.gov. A trial is counted once per group and per outcome domain it covers. The number in brackets after each group is its total trials for this condition.

none1–23–910–2930 or more
Registered non-drug trials for Alopecia Areata by intervention group and primary outcome domain
Intervention groupFatigue and energyPost-exertional symptomsCognitionMood, anxiety and wellbeingPainSleepPhysical function and exercise capacityHeart rate, blood pressure and autonomicBreathing and lung functionQuality of lifeWeight and metabolic markersInflammation and other biomarkersSymptom severity and disease activityClinical events, survival and healthcare useFeasibility, adherence and safetyNot classified
Mind-body and psychological approaches (4)···4·····2·11·1·
Cognitive training and education (3)···1·····1··1·2·
Oxygen, light, temperature and manual therapies (11)··········2·1126
Supplements and nutraceuticals (13)····1·····2·1128
Other behavioural, not yet classified (1)···············1

The table scrolls sideways: 16 outcome columns.

No trials found for this condition in: Exercise and physical activity; Rehabilitation and therapy services; Breathing and respiratory training; Diet, fasting and nutrition; Sleep and circadian approaches; Neuromodulation and electrical stimulation; Other devices and digital tools; Care delivery and health services.

Where the gaps are

Outcomes not found as a primary outcome in a group's trials

  • Among the 13 trials of supplements and nutraceuticals found, none used mood, anxiety and wellbeing as a primary outcome (5 trials of other approaches did).
  • Among the 11 trials of oxygen, light, temperature and manual therapies found, none used mood, anxiety and wellbeing as a primary outcome (5 trials of other approaches did).
  • Among the 13 trials of supplements and nutraceuticals found, none used quality of life as a primary outcome (3 trials of other approaches did).
  • Among the 11 trials of oxygen, light, temperature and manual therapies found, none used quality of life as a primary outcome (3 trials of other approaches did).

Questions studied but with no results posted

  • Mind-body and psychological approaches × mood, anxiety and wellbeing: 4 trials registered, none with results posted

Design a trial with DecenTrial (beta) Fund a component of this work

A gap here means no matching trial was found among those searched, not that an approach would work. About one trial in six has primary outcomes the rules cannot classify, so a few gaps may be measured under another name. Some gaps are gaps for good reason.

Most-studied approaches for Alopecia Areata

Download this matrix (CSV) Non-drug evidence map Evidence brief RepurpOS condition page Condition page

How outcomes are grouped

Each trial's primary outcome measures are sorted into domains by keyword rules. 15 trials for this condition have primary outcomes the rules could not classify; they appear in the last column rather than being dropped. Checked against 90 hand-labelled outcomes; on a held-out sample of 30, the rules agreed with the hand label for 20 before adjustment, and every outcome they labelled was labelled correctly (misses were left unclassified).

Trial selection and exclusions follow the non-drug evidence map method. Source: ClinicalTrials.gov, searched 2026-11-16.